Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 02-2020 | 12-2019 | 02-2019 | 12-2018 | 02-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69 | 0 | 313 | 313 | 400 |
| Other current assets | 0 | 0 | 0 | 91 | 60 |
| TOTAL | $139 | $0 | $404 | $404 | $460 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | N/A | 0 | 0 |
| Investments And Advances | 60,883 | 0 | 65,242 | 64,877 | 64,870 |
| Other Non-Current Assets | 0 | 2 | 0 | 0 | 0 |
| TOTAL | $60,883 | $2 | $65,242 | $64,877 | $64,870 |
| Total Assets | $61,022 | $3 | $65,646 | $65,646 | $65,330 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,765 | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | 300 | 225 | 23 | 22 | 20 |
| Accrued Expenses | N/A | 2,723 | N/A | 0 | 0 |
| Other current liabilities | N/A | 102 | N/A | 0 | 0 |
| TOTAL | $300 | $6,814 | $23 | $23 | $20 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 55,722 | 0 | 60,623 | 60,316 | 60,310 |
| TOTAL | $55,722 | $N/A | $60,623 | $60,316 | $60,310 |
| Total Liabilities | $56,022 | $6,814 | $60,646 | $60,646 | $60,330 |
| Shareholders' Equity | |||||
| Common Shares | 3,808 | 1 | 4,426 | 4,732 | 4,730 |
| Retained earnings | 1,192 | -54,527 | 574 | 574 | 260 |
| Other shareholders' equity | 0 | 29,070 | 0 | -306 | 10 |
| TOTAL | $5,000 | $-6,811 | $5,000 | $5,000 | $5,000 |
| Total Liabilities And Equity | $61,022 | $3 | $65,646 | $65,646 | $65,330 |